Exxel Pharma - Crunchbase Company Profile & Funding

Q: Where is Exxel Pharma's headquarters?

Exxel Pharma is located in Aurora, Colorado, United States.

Q: When was the last funding round for Exxel Pharma?

Exxel Pharma closed its last funding round on obfuscated from a Debt Financing round.

Q: How much funding has Exxel Pharma raised to date?

Exxel Pharma has raised obfuscated.

Overview

Exxel Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Exxel Pharma

CB Rank

131032

Exxel Pharma is a pharmaceutical company that offers innovative medicines for chronic cough and other unmet medical needs.

Founded

obfuscation

Private

Debt Financing

Aurora, Colorado, United States

1-10

www.exxelpharma.com

Health Care

Medical

Pharmaceutical

Funding Rounds

Debt Financing

OBF

obfuscation

Key People

Soren Møgelsvang: President and CEO

Details

Legal Name

Exxel Pharma Inc

Operating Status

Active

Company Type

For Profit

Phone Number

+1 720-261-1109

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

EX937

An oral small molecule that peripherally inhibits FAAH enzyme to treat refractory chronic cough by reducing neuronal hypersensitivity.

EX14280 and EX14663

Globally active FAAH inhibitors designed to enhance anandamide signaling in the brain for treating social anxiety and autism spectrum disorders.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing
obfuscated obfuscation	Debt Financing - Exxel Pharma	—	obfuscated obfuscation	—	Debt Financing